Clinical Trial Update: Real-world Outcomes of Aplastic Anemia Patients Treated With Eltrombopag: A Medical Claims Database Study

View source ↗

Summary

This study analyzes real-world outcomes of aplastic anemia patients treated with eltrombopag using a medical claims database.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Eltrombopag (eltrombopag)
• Promacta (eltrombopag)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Anemia, Aplastic | Status: COMPLETED